Danaher schedules Q2 earnings call, shares steady in S&P 500
27.06.2026 - 11:46:01 | ad-hoc-news.de
By Stefan Krueger, Long-Term & Business Model desk. Reviewed prior to publication on 2026-06-27, 11:45.
Danaher Corp. (US2358511028) has scheduled its Q2 2026 earnings conference call, according to a PR Newswire-based update relayed by Intellectia AI four days ago. Intellectia summary of the Q2 2026 earnings call schedule The S&P 500-listed company trades on the NYSE under ticker DHR.
What the call schedule shows
The Intellectia note cites PR Newswire as the source for Danaher’s Q2 2026 earnings conference call announcement, indicating the company has set a time for management to discuss quarterly results with analysts. PR Newswire announcement on the Q2 2026 earnings conference call Earnings calls typically cover revenue trends, segment performance and updated guidance.
Danaher’s upcoming call will follow its recent trading sessions in which the shares closed at 195.67 US dollars on June 26, 2026, with a gain of 1.27 percent on the day on NYSE, according to MarketBeat. MarketBeat overview of Danaher’s latest share performance Extended trading data show the stock at 195.13 US dollars as of the same evening.
Saturday focus on long-term setup
Analyst aggregation by PandaForecast notes that Danaher’s latest session on June 26, 2026 was positive, with an intraday range between 192.29 and 196.19 US dollars and volume around 5.94 million shares. PandaForecast data on Danaher’s recent trading and analyst expectations The same source cites an average analyst target near 242.35 US dollars, providing a reference point for longer-term expectations.
Finanzen100 lists Danaher within the S&P 500 index and categorizes the company in the medical equipment and life-sciences tools segment, under WKN 866197 for German investors tracking the shares in euros. Finanzen100 profile of Danaher with WKN and sector classification That classification highlights Danaher’s role as a diversified supplier to laboratories, healthcare providers and industrial customers.
All news and analysis on the Danaher shares
Further updates, background pieces and price data on Danaher are available on the ad-hoc-news topic page and the company’s investor relations site.
The business behind the stock
Danaher’s core business spans diagnostics, life-sciences and environmental and applied solutions, with key platforms such as Cepheid molecular diagnostic systems and Cytiva bioprocess equipment supporting pharmaceutical and biotech production. Danaher overview of its businesses and product platforms The company generates recurring revenue from consumables, reagents and service contracts linked to installed instruments.
Where the shares trade today
Danaher shares (US2358511028) last traded at 195.67 US dollars on the NYSE at the close on 2026-06-26, 15:59 Eastern, based on MarketBeat data. MarketBeat quote page for Danaher on NYSE In extended trading that evening the stock was quoted at 195.13 US dollars.
Key data on the Danaher shares
- Company: Danaher Corporation
- ISIN: US2358511028
- WKN: 866197
- Ticker: DHR
- Trading venue: NYSE
- Price (as of 2026-06-26, 15:59): 195.67 USD
- Market cap: around 140 billion USD (as of June 2026, based on major financial data providers)
- Sector / industry: Health Care Equipment & Life Sciences Tools
- Index membership: S&P 500
- Next earnings date: Q2 2026 earnings call scheduled, exact time per PR Newswire call notice
Disclaimer: This text is for informational purposes only and does not constitute investment advice, a recommendation to buy or sell securities, or a forecast of future performance. All data are based on sources cited and may change over time.
